Tenaya Therapeutics, Inc.TNYANASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Gross Profit | -4 | -9 | -9 |
| Operating Income | -73 | -126 | -131 |
| Net Income | -73 | -124 | -124 |
| EBITDA | -69 | -115 | -115 |
| EPS Diluted | -1.69 | -2.76 | -1.68 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 38 | 95 | 46 |
| Total Current Assets | 255 | 194 | 112 |
| Total Assets | 317 | 279 | 171 |
| Total Current Liabilities | 22 | 24 | 23 |
| Total Liabilities | 38 | 36 | 31 |
| Total Equity | 279 | 243 | 139 |
| Total Debt | 16 | 15 | 12 |
| Net Debt | -22 | -80 | -33 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -61 | -104 | -102 |
| Capital Expenditure | -25 | -21 | -1 |
| Free Cash Flow | -86 | -125 | -103 |
| Stock-Based Comp | 3 | 11 | 15 |
| Net Change in Cash | -90 | 57 | -49 |